comparemela.com

Page 13 - Keli Baker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ginkgo Bioworks : Announces Investor Day and Participation in Upcoming Investor Conferences

BOSTON, May 24, 2021 /PRNewswire/  Ginkgo Bioworks, Inc. , which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on. | May 24, 2021

Ginkgo Bioworks Announces Investor Day and Participation in Upcoming Investor Conferences

Ginkgo Bioworks Announces Investor Day and Participation in Upcoming Investor Conferences Virtual Investor Day scheduled for Thursday, June 24, 2021 News provided by Share this article BOSTON, May 24, 2021 /PRNewswire/  Ginkgo Bioworks, Inc. ( Ginkgo ), which is building the leading horizontal platform for cell programming, today announced that it will hold a virtual Investor Day on Thursday, June 24, 2021, beginning at 1:00pm ET. The Investor Day will feature conversations with Ginkgo s Founders, a virtual Foundry Tour, presentations by Ginkgo senior management, and a showcase of customer programs. The Investor Day event registration and webcast details are available at  Ginkgo also announced today that the company will be participating in the following upcoming virtual investor conferences:

Biotech firm Ginkgo to merge with Harry Sloan-led SPAC in $17 5 billion deal

Biotech firm Ginkgo to merge with Harry Sloan-led SPAC in $17 5 billion deal
reuters.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from reuters.com Daily Mail and Mail on Sunday newspapers.

Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming

Ginkgo Bioworks to Become a Public Company and Expand its Leading Platform for Cell Programming Ginkgo is building the leading horizontal platform for synthetic biology, making it possible to program cells as easily as we can program computers and enabling innovation across industries, including therapeutics, industrials, food and agriculture News provided by Share this article BOSTON and LOS ANGELES, May 11, 2021 /PRNewswire/ Business combination with Soaring Eagle Acquisition Corp. (Nasdaq:SRNG) values Ginkgo Bioworks, Inc. at a $15 billion pre-money equity valuation and is expected to provide up to $2.5 billion of primary proceeds. Institutional investors have committed $775 million in an oversubscribed PIPE, with anchor investments from Baillie Gifford, Putnam Investments, and funds and accounts managed by Counterpoint Global (Morgan Stanley Investment Management). New investors including accounts advised by ARK Investment Management LLC, ArrowMark Partners, Bain Capital

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.